Metabolic Syndrome Causing Cognitive Impairment in Patients With Schizophrenia: A Systematic Review.

Autor:	Saxena A; Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA., Patel D; Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA., Ayesha IE; Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA., Monson NR; Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA., Klair N; Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA., Patel U; Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA., Khan S; Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Oct 24; Vol. 15 (10), pp. e47587. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2023).
DOI:	10.7759/cureus.47587
Abstrakt:	Schizophrenia often exhibits characteristics like cognitive deficits, and individuals with the condition are at a higher risk of developing metabolic syndrome. The effect of metabolic syndrome on schizophrenia-related cognitive impairment is still unknown, though. This systematic review aims to investigate the association between metabolic syndrome and cognitive impairment in patients with schizophrenia, specifically focusing on neurocognitive and social cognitive performance. Schizophrenia significantly strains the public healthcare system since it necessitates tremendous resources and care to support those suffering from the condition. Furthermore, patients with schizophrenia are more susceptible to developing obesity than the general population, leading to a higher possibility of developing metabolic syndrome. The gut microbiota has been recognized as a critical regulator of bidirectional interactions between the central nervous system and the gastrointestinal tract. Emerging evidence suggests that dysbiosis of the gut microbiota is closely linked to the development of both schizophrenia and obesity, sharing common pathophysiological mechanisms, particularly immune inflammation. In this systematic review, we examine the existing literature to explore the relationship between metabolic syndrome and cognitive impairment in individuals with schizophrenia. By synthesizing available evidence on neurocognitive and social cognitive performance, we aim to provide a comprehensive understanding of the association between metabolic syndrome and cognitive deficits in schizophrenia. The findings from this review will contribute to our knowledge of the complex interplay between metabolic abnormalities, gut microbiota dysbiosis, and cognitive impairments in patients with schizophrenia. This understanding may facilitate the development of novel interventions targeting metabolic syndrome as a potential avenue for improving cognitive outcomes in individuals with schizophrenia. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Saxena et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu